Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease
Open Access
- 1 October 2008
- Vol. 60 (2), 247-257
- https://doi.org/10.1016/j.neuron.2008.10.001
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- 100 Years and Counting: Prospects for Defeating Alzheimer's DiseaseScience, 2006
- Intracellularly generated amyloid‐β peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cellsJournal of Neurochemistry, 2004
- Clearance of Alzheimer's Aβ PeptideNeuron, 2004
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivoEuropean Journal of Neuroscience, 2004
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targetsNeurochemistry International, 2002
- Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000